HomeARTL • NASDAQ
add
Artelo Biosciences Inc
Previous close
$0.94
Day range
$0.91 - $0.94
Year range
$0.82 - $1.59
Market cap
3.02M USD
Avg Volume
823.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.38M | -8.11% |
Net income | -2.37M | 4.47% |
Net profit margin | — | — |
Earnings per share | -0.72 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 746.00K | -90.20% |
Total assets | 3.52M | -66.05% |
Total liabilities | 2.86M | 250.43% |
Total equity | 652.00K | — |
Shares outstanding | 3.28M | — |
Price to book | 4.70 | — |
Return on assets | -144.83% | — |
Return on capital | -320.79% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.37M | 4.47% |
Cash from operations | -1.60M | 45.72% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.59M | 1.73% |
Free cash flow | -872.88K | 56.53% |
About
Founded
May 2, 2011
Headquarters
Website
Employees
6
